Garlotti is a modern hybrid-indica strain whose genetic lineage remains largely undocumented, as breeders have not publicly confirmed its complete cross or origin history. While Gelatti is identified as one of its parents, the complete ancestral story remains unverified and thin in the current record. This lack of documentation is common in modern genetics, and there is no consensus on its specific historical development or the identities of its other contributors.

The chemical profile of Garlotti is defined by a complex array of terpenes, led by caryophyllene, limonene, and humulene, followed by myrcene, beta-pinene, pinene, linalool, bisabolol, and terpinolene in descending order. This strain carries an estimated THC content of approximately 16.8 percent, with a negligible CBD presence estimated at 0.03 percent. Growers can expect a moderate cultivation difficulty with a flowering time of 60 days, suitable for both indoor and outdoor environments, and generally resulting in a high yield.

In terms of effects, Garlotti is noted for providing a sensation of relaxation and a notable boost in focus. These properties make it a viable cultivar for users seeking management for pain, stress, or sleep-related issues. Despite its presence in the modern market, there are currently no notable offspring recorded for this strain, leaving its genetic legacy singular within the available documentation.